Cargando…

SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity

The SARS-CoV-2 spike is the primary target of virus-neutralizing antibodies and critical to the development of effective vaccines against COVID-19. Here, we demonstrate that the prefusion-stabilized two-proline “S2P” spike—widely employed for laboratory work and clinical studies—unfolds when stored...

Descripción completa

Detalles Bibliográficos
Autores principales: Olia, Adam S., Tsybovsky, Yaroslav, Chen, Steven J., Liu, Cuiping, Nazzari, Alexandra F., Ou, Li, Wang, Lingshu, Kong, Wing-Pui, Leung, Kwan, Liu, Tracy, Stephens, Tyler, Teng, I-Ting, Wang, Shuishu, Yang, Eun Sung, Zhang, Baoshan, Zhang, Yi, Zhou, Tongqing, Mascola, John R., Kwong, Peter D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393506/
https://www.ncbi.nlm.nih.gov/pubmed/34461095
http://dx.doi.org/10.1016/j.jbc.2021.101127
_version_ 1783743741843996672
author Olia, Adam S.
Tsybovsky, Yaroslav
Chen, Steven J.
Liu, Cuiping
Nazzari, Alexandra F.
Ou, Li
Wang, Lingshu
Kong, Wing-Pui
Leung, Kwan
Liu, Tracy
Stephens, Tyler
Teng, I-Ting
Wang, Shuishu
Yang, Eun Sung
Zhang, Baoshan
Zhang, Yi
Zhou, Tongqing
Mascola, John R.
Kwong, Peter D.
author_facet Olia, Adam S.
Tsybovsky, Yaroslav
Chen, Steven J.
Liu, Cuiping
Nazzari, Alexandra F.
Ou, Li
Wang, Lingshu
Kong, Wing-Pui
Leung, Kwan
Liu, Tracy
Stephens, Tyler
Teng, I-Ting
Wang, Shuishu
Yang, Eun Sung
Zhang, Baoshan
Zhang, Yi
Zhou, Tongqing
Mascola, John R.
Kwong, Peter D.
author_sort Olia, Adam S.
collection PubMed
description The SARS-CoV-2 spike is the primary target of virus-neutralizing antibodies and critical to the development of effective vaccines against COVID-19. Here, we demonstrate that the prefusion-stabilized two-proline “S2P” spike—widely employed for laboratory work and clinical studies—unfolds when stored at 4 °C, physiological pH, as observed by electron microscopy (EM) and differential scanning calorimetry, but that its trimeric, native-like conformation can be reacquired by low pH treatment. When stored for approximately 1 week, this unfolding does not significantly alter antigenic characteristics; however, longer storage diminishes antibody binding, and month-old spike elicits virtually no neutralization in mice despite inducing high ELISA-binding titers. Cryo-EM structures reveal the folded fraction of spike to decrease with aging; however, its structure remains largely similar, although with varying mobility of the receptor-binding domain. Thus, the SARS-CoV-2 spike is susceptible to unfolding, which affects immunogenicity, highlighting the need to monitor its integrity.
format Online
Article
Text
id pubmed-8393506
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-83935062021-08-27 SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity Olia, Adam S. Tsybovsky, Yaroslav Chen, Steven J. Liu, Cuiping Nazzari, Alexandra F. Ou, Li Wang, Lingshu Kong, Wing-Pui Leung, Kwan Liu, Tracy Stephens, Tyler Teng, I-Ting Wang, Shuishu Yang, Eun Sung Zhang, Baoshan Zhang, Yi Zhou, Tongqing Mascola, John R. Kwong, Peter D. J Biol Chem Research Article The SARS-CoV-2 spike is the primary target of virus-neutralizing antibodies and critical to the development of effective vaccines against COVID-19. Here, we demonstrate that the prefusion-stabilized two-proline “S2P” spike—widely employed for laboratory work and clinical studies—unfolds when stored at 4 °C, physiological pH, as observed by electron microscopy (EM) and differential scanning calorimetry, but that its trimeric, native-like conformation can be reacquired by low pH treatment. When stored for approximately 1 week, this unfolding does not significantly alter antigenic characteristics; however, longer storage diminishes antibody binding, and month-old spike elicits virtually no neutralization in mice despite inducing high ELISA-binding titers. Cryo-EM structures reveal the folded fraction of spike to decrease with aging; however, its structure remains largely similar, although with varying mobility of the receptor-binding domain. Thus, the SARS-CoV-2 spike is susceptible to unfolding, which affects immunogenicity, highlighting the need to monitor its integrity. American Society for Biochemistry and Molecular Biology 2021-08-27 /pmc/articles/PMC8393506/ /pubmed/34461095 http://dx.doi.org/10.1016/j.jbc.2021.101127 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Olia, Adam S.
Tsybovsky, Yaroslav
Chen, Steven J.
Liu, Cuiping
Nazzari, Alexandra F.
Ou, Li
Wang, Lingshu
Kong, Wing-Pui
Leung, Kwan
Liu, Tracy
Stephens, Tyler
Teng, I-Ting
Wang, Shuishu
Yang, Eun Sung
Zhang, Baoshan
Zhang, Yi
Zhou, Tongqing
Mascola, John R.
Kwong, Peter D.
SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity
title SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity
title_full SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity
title_fullStr SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity
title_full_unstemmed SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity
title_short SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity
title_sort sars-cov-2 s2p spike ages through distinct states with altered immunogenicity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393506/
https://www.ncbi.nlm.nih.gov/pubmed/34461095
http://dx.doi.org/10.1016/j.jbc.2021.101127
work_keys_str_mv AT oliaadams sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity
AT tsybovskyyaroslav sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity
AT chenstevenj sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity
AT liucuiping sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity
AT nazzarialexandraf sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity
AT ouli sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity
AT wanglingshu sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity
AT kongwingpui sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity
AT leungkwan sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity
AT liutracy sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity
AT stephenstyler sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity
AT tengiting sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity
AT wangshuishu sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity
AT yangeunsung sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity
AT zhangbaoshan sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity
AT zhangyi sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity
AT zhoutongqing sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity
AT mascolajohnr sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity
AT kwongpeterd sarscov2s2pspikeagesthroughdistinctstateswithalteredimmunogenicity